Study record managers: refer to the Data Element Definitions if submitting registration or results information. Female orgasmic disorder is characterized by a recurrent or persistent difficulty in achieving orgasm during sexual activity. Epidemiological studies in Sweden and the United Kingdom have found similar rates of orgasm disorder. Studies of drugs with actions of increasing genital vasodilation in response to sexual stimulation eg alprostadil, sildenafil, or phentolamine have generally been found to be unsuccessful or to have extremely limited efficacy in reversing female sexual dysfunction Basson, ; Segraves, There have been fewer studies of pharmacological treatment for hypoactive sexual desire disorder in premenopausal women.
However, she's certainly right that it's not really a great idea to just bounce you around to different medications and dosages on a whim, and since some of these side effects including the anorgasmia are generally transitory I think she's probably right to wait on it a little bit. Ego-dystonic sexual orientation Paraphilia Fetishism Voyeurism Sexual maturation disorder Sexual relationship disorder. Talk with your doctor and family members or friends about deciding to join a study. Br J Psychiatry ; I'd get a second opinion if I were you. My primary reason for taking an Wellbutirn is Anorgasmic wellbutrin daily headache, wellbhtrin it has also done wonders for Anorgasmic wellbutrin mood and evened out some horrible mood swings I was having with perimenopause. This material is Anorhasmic for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Business breasts boss he opened her. Bupropion Rating Summary
Dizziness is more common with tricyclic antidepressants and monoamine oxidase inhibitors MAOIs than with other antidepressants. Orgasms vary in intensity, and women vary in the frequency of their Escort kad n adana and the amount of stimulation needed to trigger an orgasm. Wellbutrin was Anorgasmic wellbutrin at that time to help with that! If these develop, talk to your doctor right away because they may be signs of bipolar disorder or another serious disorder. My doctor believes that I have benefited from the "lithium boost", whereby the lithium potentiates the Lexapro. Although having more energy can be a good thing, it may mean you can't relax or sit still even if you want to. Explore Apps. Approach to Anorgasmic wellbutrin patient with a sleep or wakefulness disorder. Coffee after dinner? Anorgasmic wellbutrin, I do have experience with Zoloft and Wellbutrin. I did not notice symptoms from eithe. There are other antidepressants out there. Free E-newsletter Subscribe to Housecall Our general interest Anorgasmic wellbutrin keeps you up to date on a wide variety of health topics.
Sexual side effects of antidepressant drugs are commonly observed 1.
- Hi all, have been on Zoloft 50mg for about 4 months for depression and anxiety - was doing ok I know, it's a small dose yet three weeks ago I had a major relapse, including goodbye libido.
- Most antidepressant side effects aren't dangerous, but they can be bothersome.
- Forum Rules.
- A Newt?
- Give us feedback!
Anorgasmia is a type of sexual dysfunction in which a person cannot achieve orgasm despite adequate stimulation.
Anorgasmia is far more common in females 4. The problem is greater in women who are post-menopause. Anorgasmia can often cause sexual frustration. The condition is sometimes classified as a psychiatric disorder.
However, it can also be caused by medical problems such as diabetic neuropathy , multiple sclerosis , genital mutilation on either gender, complications from genital surgery, pelvic trauma such as from a straddle injury caused by falling on the bars of a climbing frame, bicycle or gymnastics beam , hormonal imbalances, total hysterectomy , spinal cord injury , cauda equina syndrome , uterine embolisation, childbirth trauma vaginal tearing through the use of forceps or suction or a large or unclosed episiotomy , vulvodynia and cardiovascular disease.
A common cause of situational anorgasmia, in both men and women, is the use of anti-depressants , particularly selective serotonin reuptake inhibitors SSRIs. Another cause of anorgasmia is opiate addiction , particularly to heroin. Primary anorgasmia is a condition where one has never experienced an orgasm. This is significantly more common in women, although it can occur in men who lack the gladipudendal bulbocavernosus reflex. Frustration, restlessness, and pelvic pain or a heavy pelvic sensation may occur because of vascular engorgement.
On occasion, there may be no obvious reason why orgasm is unobtainable. In such cases, women report that they are unable to orgasm even if they have a caring, skilled partner, adequate time and privacy, and an absence of medical issues which would affect sexual satisfaction. Some social theorists [ who? It is thought that this view may impede some women — perhaps those raised in a more repressed environment — from being able to experience natural and healthy sexual feeling.
Secondary anorgasmia is the loss of the ability to have orgasms as opposed to primary anorgasmia which indicates a person who has never had an orgasm.
Or loss of the ability to reach orgasm of past intensity. The cause may be alcoholism, depression, grief, pelvic surgery such as total hysterectomy or injuries, certain medications, illness, estrogen deprivation associated with menopause , or rape.
At more advanced ages, the prostate is less likely to grow during that person's remaining lifetime. Removal of the prostate frequently damages or even completely removes these nerves, making sexual response unreasonably difficult. People who are orgasmic in some situations may not be in others. A person may have an orgasm from one type of stimulation but not from another, achieve orgasm with one partner but not another, or have an orgasm only under certain conditions or only with a certain type or amount of foreplay.
These common variations are within the range of normal sexual expression and should not be considered problematic. A person who is troubled by experiencing situational anorgasmia should be encouraged to explore alone and with their partner those factors that may affect whether or not they are orgasmic, such as fatigue, emotional concerns, feeling pressured to have sex when they are not interested, or a partner's sexual dysfunction. In the relatively common case of female situational anorgasmia during penile-vaginal intercourse, some sex therapists recommend that couples incorporate manual or vibrator stimulation during intercourse, or using the female-above position as it may allow for greater stimulation of the clitoris by the penis or pubic symphysis or both, and it allows the woman better control of movement.
Effective treatment for anorgasmia depends on the cause. In the case of women suffering from psychological sexual trauma or inhibition, psychosexual counselling might be advisable and could be obtained through general practitioner GP referral. Women suffering from anorgasmia with no obvious psychological cause would need to be examined by their GP to check for absence of disease.
They would then need to be referred to a specialist in sexual medicine. The specialist would check the patient's blood results for hormonal levels, thyroid function and diabetes, evaluate genital blood flow and genital sensation, as well as giving a neurological work-up to determine the degree if any of nerve damage.
Recently, it has been proposed to add a subtype of FOD, called reduced orgasmic intensity, and field trials are underway to assess the suitability of this proposal. Just as with erectile dysfunction in men, lack of sexual function in women may be treated with hormonal patches or tablets to correct hormonal imbalances, clitoral vacuum pump devices and medication to improve blood flow, sexual sensation and arousal.
Many practitioners today treat both men and women who have SSRI-induced anorgasmia with sildenafil , more commonly known as Viagra. While this approach is known to work well in men with sexual dysfunction, it is only recently that the effectiveness of sildenafil in women with sexual dysfunction is coming to light. A recent study by H. Nurnberg et al. Another option for women who have SSRI-induced anorgasmia is the use of vardenafil. Vardenafil is a type 5 phosphodiesterase PDE5 inhibitor that facilitates muscle relaxation and improves penile erection in men.
However, there is much controversy about the efficiency of the drug used in the reversal of female sexual dysfunction. A study by A. Ashton M. The NIH states that yohimbine hydrochloride has been shown in human studies to be possibly effective in the treatment of male impotence resulting from erectile dysfunction or SSRI usage e. From Wikipedia, the free encyclopedia. Anorgasmia Other names Coughlan's syndrome Specialty Psychiatry , gynecology , urology Anorgasmia is a type of sexual dysfunction in which a person cannot achieve orgasm despite adequate stimulation.
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Abnormal Psychology Sixth Edition. Bumiller, E. July The Journal of Clinical Psychiatry. American Family Physician. Sexual dysfunction in women. In: Ferri FF. Ferri's Clinical Advisor Louis, Mo.
The British Journal of Psychiatry. British Journal of Urology 77 : A. British Journal of Urology 77 : — Retrieved 6 December Family Practice. Journal of Sexual Medicine , 7, — Geore Nurnberg, M. Psychiatric Services. Angulo; et al. International Journal of Impotence Research. Ashton Archived from the original on 1 August Retrieved 13 December Asian Journal of Andrology. Journal of Clinical Psychopharmacology. Retrieved 4 April ICD - 10 : F Adult personality and behavior. Ego-dystonic sexual orientation Paraphilia Fetishism Voyeurism Sexual maturation disorder Sexual relationship disorder.
Factitious disorder Munchausen syndrome Impulse control disorder Dermatillomania Kleptomania Pyromania Trichotillomania Personality disorder. Childhood and learning. X-linked intellectual disability Lujan—Fryns syndrome. Pervasive Specific. Mood affective. Neurological and symptomatic. Delirium Organic brain syndrome Post-concussion syndrome. Neurotic , stress -related and somatoform. Adjustment disorder with depressed mood.
Depersonalization disorder Dissociative identity disorder Fugue state Psychogenic amnesia. Physiological and physical behavior. Postpartum depression Postpartum psychosis.
Arousal Erectile dysfunction Female sexual arousal disorder Desire Hypersexuality Hypoactive sexual desire disorder Orgasm Anorgasmia Delayed ejaculation Premature ejaculation Sexual anhedonia Pain Nonorganic dyspareunia Nonorganic vaginismus.
Psychoactive substances, substance abuse and substance-related. Schizophrenia , schizotypal and delusional. Brief reactive psychosis Schizoaffective disorder Schizophreniform disorder. Childhood schizophrenia Disorganized hebephrenic schizophrenia Paranoid schizophrenia Pseudoneurotic schizophrenia Simple-type schizophrenia.
Categories : Orgasm Behavioural syndromes associated with physiological disturbances and physical factors Psychiatric diagnosis. Hidden categories: All articles with broken links to citations Use dmy dates from May All articles with specifically marked weasel-worded phrases Articles with specifically marked weasel-worded phrases from July Articles needing additional references from June All articles needing additional references.
Mayo Clinic Marketplace Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. I have been on Zoloft, Lexapro, Effexor, Paxil and never had this happen. Evidence-Based Reviews. Mayo Clinic Marketplace Check out these best-sellers and special offers on books and newsletters from Mayo Clinic. J Clin Psychiatry ,
Anorgasmic wellbutrin. References
This practice may work when drugs that have a short half-life, such as sertraline, paroxetine, clomipramine, and fluvoxamine are used, but will not work with drugs that have a very long half-life, such as fluoxetine. A number of patients with drug induced sexual dysfunction can be helped by a little known technique of injection of the prostaglandin alprostadil into the corpus cavernosum of the penis Caverject Upjohn.
This can produce an erection in some men with erectile dysfunction. Most men claim that this injection with a small bore needle is almost painless. However, a recent report of using a p llet or microsuppository formulation that is used intraurethrally MUSE [Medicated Urethral System for Erection] - Vivus suggests that this technique may work as well without the need for injection This is marketed as a sterile foil pouch containing a pellet 1.
Pressing a button pushes the pellet into the urethra. Results were similar regardless of age or cause of impotence Padma-Nathan et al, In terms of patient management, some guidelines can be crystallized from the available literature. First, it is crucial to elicit a reasonable sexual history and ask directly about difficulties with libido sexual drive , orgasm, erection, and satisfaction with sexual activity. Be clear with patients up front that antiobsessional and antidepressant medications are often associated with sexual difficulties.
When identified, sometimes sexual problems can be lessened with simple dose reduction. Occasionally, these side effects diminish over time, but by no means in the majority of patients. Since there are now a number of effective antiobsessional drugs, it may be worth trying a switch to another drug, but if patients have had a good response, they may be reluctant to do this.
Patients may have sexual difficulties on one or two antiobsessional agents, and perform normally on others. If for some reason you do not want to change medication, several possible antidotes exist.
Yohimbine is useful for anorgasmia except in patients with panic disorder, excessive agitation, or hypertension and can be given at a dose of Others have recommended chronic use of yohimbine at 5. Cyproheptadine can also be used on an as needed basis, but it often puts patients to sleep.
There is also the theoretical concern that it may reverse antiobsessional and antidepressant drug effects. Amantadine has been used on an as needed basis and may be worth a try. Bupropion, given at a dose of mg daily may correct SSRI-induced sexual dysfunction. If for some reason the patient cannot tolerate bupropion, trazodone, mg given daily can be used, especially for patients who have difficulties in developing and maintaining an erection Seagraves et al, Sometimes combinations of these agents are used.
For example, one report Seagraves et al, advocated using bupropion starting at They also give methylphenidate 10 mg daily on occasion, with beneficial results. Others recommend pemoline instead of methylphenidate as an adjunct, because it often reduces orgasm problems and has a half-life of 10 to 12 hours. Caverject and MUSE systems may be helpful for some patients. Drug holidays are being advocated more and more for the shorter acting agents. There are recent reports that ginkgo biloba, a botanical derived from tree bark, may allow for better sexual functioning for people taking SSRI's and other antidepressants.
It is now theoretically possible the new drug, Viagra, may also be useful. Above all, it is important to note the empirical nature of treating sexual difficulties and the need for flexibility. Multiple approaches, including biological and psychosocial, in an alliance with the physician, patient, and sexual partner are required. There is no way to determine in advance which patients will have sexual difficulties and then which approach will help them function.
Several drugs and combinations may have to be tried. It is also important to monitor any concomitant medical problems or other medications that may have an effect on sexual functioning. Br J Psychiatry , August 17, Seagraves RT: Reversing anorgasmia associated with serotonin uptake inhibitors [Questions and Answers].
JAMA , Seagraves RT: Treatment of drug-induced anorgasmia. McCormick S. I should probably mention that when not depressed I have a very healthy sex drivex a week Wellbutrin kicked my sex drive back into normal gear BUT right at the exact second of climax I know there must be more here with this "freaky side effect" because I personally know two people who had it while trying to quit smoking.
Any drug welcome--that question is not exclusive to Wellbutrin. I'm getting a bit desperate here. I started to list all the meds I've tried but it seemed like too much info and off topic for my questions. Make sure you mention it to your pdoc. It could revel somthing interesting about your pathology.
How long have you been on it. It can act pretty different for the first month or so that you're on it. I was on it about 4 years ago. I definitely do have odd reactions to meds though, i. Tylenol p. BUT Remeron will make me sleep for 35 hours. I ask these questions because Wellbutrin is the only med that actually made me feel Life is never perfect in every way but the way I am now is no life at all. I mean if there's a chance that it could work like Because your body changes every how many years?
I mean.. And since WB does affect one or two of the several neurotransmitters probably involved in sexual response, it's not surprising that for. Probably with time, the sexual side effects may decrease or stabilize But considering.
I know exactly what you're saying and if my sex DRIVE didn't go back to normal as well then yes definitely!! It's very hard to explain Right to the split second, you know.. Even depressed, that once every 6 weeks or so that he can corner me lol--that sounds bad but it's not like that even though it takes longer for me to get aroused it works.
That's actually a side effect usually associated with the amphetamines as a result of neurotransmitter depletion - different mechanism from WB.
My guess would be that at some point noradrenaline levels have been held at an elevated level long enough that your body refuses to release enough more for that extra spark needed.
Or, maybe in finding a way around the reuptake inhibition, it's found a way to nuke its own stores Crazy Meds! It's possible that supplementing with phenylalanine or tyrosine can help, although that can backfire with bipolar disorder. Or maybe a lower dose of Wellbutrin can work almost as well but with fewer side effects. I am not bipolar, Loon.
I have always been in and out of depression though. I mean even when I don't feel that I'm depressed people are always telling me to smile I don't get that!! Prozac was the latest attempt. I got sexual side-effects from several of the AD's I've been on. Total anorgasmia on Effexor and Cymbalta, though the problems with Cymbalta seem to have passed with time, letting me have an orgasm, but just not intense.
On Lexapro I was able to have an orgasm, but it seemed to take forever. It works like a charm. More info can be found in this post.
Wellbutrin was added at that time to help with that! But It didn't seem to counteract those sexual dampening of those two. I used to have a pretty high sex drive which does not match my wife's by any stretch! With the Effexor and Zyprexa, it brought me down quite a bit.
Now I'm still on WB, but have added back a lower dose of Zyprexa and now Lithium and the Zyprexa seems to have knocked back my drive some, but the ability to orgasm is still there--albeit a little delayed. Sometimes I still have to really concentrate to go, and the wife thinks it is her that she is not getting me to go Totally unexpected since I heard it was a "stimulant" and one of the meds with fewest side effects.
I have been on Zoloft, Lexapro, Effexor, Paxil and never had this happen.
Sex and antidepressants: When to switch drugs or try an antidote | MDedge Psychiatry
Study record managers: refer to the Data Element Definitions if submitting registration or results information. Female orgasmic disorder is characterized by a recurrent or persistent difficulty in achieving orgasm during sexual activity. Epidemiological studies in Sweden and the United Kingdom have found similar rates of orgasm disorder.
Studies of drugs with actions of increasing genital vasodilation in response to sexual stimulation eg alprostadil, sildenafil, or phentolamine have generally been found to be unsuccessful or to have extremely limited efficacy in reversing female sexual dysfunction Basson, ; Segraves, There have been fewer studies of pharmacological treatment for hypoactive sexual desire disorder in premenopausal women.
In addition one controlled study Crenshaw et al, and several clinical series indicate that bupropion may have prosexual effects in non-depressed females Modell et al, A single blind study Segraves et al, found that bupropion increased the frequency of episodes of sexual arousal and desire for sexual activity in women diagnosed with hypoactive sexual desire disorder.
A recent multicenter, double-blind, fixed dose study of females with global, acquired hypoactive sexual desire disorder found evidence that an exposure to to mg bupropion XL increased orgasm and pleasure as measured by the CSFQ-F. In this pilot study, all women had total serum testosterone levels within normal limits and were in stable, non-conflictual relationships.
All patients had no evidence of psychiatric disorder and no evident etiology to their sexual complaint. All were pre-menopausal. The pilot study observed the effects of drug treatment for four months.
Significant change in measures of sexual orgasm occurred as early as day There are no currently approved pharmacological treatments for women with orgasmic disorder.
The purpose of this study is to delineate the effects of bupropion XL in women with global orgasmic disorder, using double blind conditions in an 8 week flexible dose multisite comparison of bupropion XL and placebo. It is hypothesized that bupropion XL will increase orgasm completion.
The primary objective of this study is to evaluate the effect of bupropion XL on the ease and frequency of achieving orgasm in sexual activity. Secondary objectives will be to investigate the effects of bupropion XL on changes in sexual arousal and sexual pleasure.
The investigator can increase the dose to mg per day at Day 28 if clinically indicated. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.
For general information, Learn About Clinical Studies. Meet operational definition of global female orgasmic disorder:. Presence of hypoactive sexual desire disorder as defined below:. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms x. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government. Read our disclaimer for details. Last Update Posted : July 20, Study Description. A recently completed multi-site double-blind placebo-controlled study found that bupropion Wellbutrin XL increased female orgasmic function in a group of pre-menopausal women with a diagnosis of hypoactive sexual desire disorder.
The purpose of this study is to ascertain whether bupropion will improve orgasmic function in pre-menopausal women with a primary complaint of idiopathic orgasmic disorder who do not have hypoactive sexual desire disorder.
This will be a multicenter, placebo-controlled, double blind study of women with a diagnosis of female orgasm disorder. During a baseline visit, psychiatric, medical, alcohol and drug, and sexual histories will be obtained. A flexible dosing paradigm will be used. Sexual desire and activity will be assessed by patient diaries, investigator interview of sexual functioning every two weeks, and by standardized questionnaire every four weeks. Secondary endpoints will be changes in sexual arousal, sexual desire, and sexual pleasure as assessed by the CSFQ-F.
Background: Female orgasmic disorder is characterized by a recurrent or persistent difficulty in achieving orgasm during sexual activity. Specific Aims: The purpose of this study is to delineate the effects of bupropion XL in women with global orgasmic disorder, using double blind conditions in an 8 week flexible dose multisite comparison of bupropion XL and placebo.
FDA Resources. Arms and Interventions. Outcome Measures. Primary Outcome Measures : The primary objective of this study is to evaluate the effect of bupropion XL on the ease and frequency of achieving orgasm in sexual activity.
Secondary Outcome Measures : Secondary objectives will be to investigate the effects of bupropion XL on changes in sexual arousal and sexual pleasure. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials. More Information. Layout table for additonal information Responsible Party: Segraves, R. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.
Orgasmic Disorder. Drug: Wellbutrin XL. Phase 2 Phase 3. Study Type :. Actual Enrollment :. Study Start Date :. Actual Primary Completion Date :. Actual Study Completion Date :. Segraves, R. D, MetroHealth Medical Center.